Minnesota medtech startup Pursuit Vascular – maker of a preventative device for catheter-related bloodstream infections – just closed a $1.6 million debt round, according to a regulatory filing. The company raised another $1.6 million about a year ago, and has several other small fundraises since its launch. Last April, it built a manufacturing facility in Maple Grove, Minnesota to […]
Pursuit Vascualr, which has developed a device to prevent catheter-related bloodstream infections in hemodialysis patients, has raised $1.3 million from angels and venture capital firms.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Catheter infection treatment startup Pursuit Vascular, based in Blaine, Minnesota, announced Monday that it has raised more than $750,000 in a bridge financing round in the first quarter. The company was looking to raise $1.03 million, according to a regulatory filing, but $750,000 “was all that we needed” said President and CEO Doug Killion, in […]
Catheter infection treatment startup Pursuit Vascular is raising $1.03 million with a mix of options and debt, roughly half of which has already been raised, according to a recent regulatory filing. The money will be used to file a 510(k) application in the summer, said president and CEO Doug Killion in an email. He added […]
Two-year-old Pursuit Vascular, based in Blaine, Minnesota, is preparing to take the next step in marketing its device to prevent blood infection related to catheters. The company, which has developed the ClearGuard technology, recently hired a CEO whose first order of business is to raise money to get the necessary regulatory approvals in U.S. and […]
Minnesota medical device and biotech companies won about $24 million in tax credits and grants from the Qualified Therapeutic Discovery program. The $1 billion initiative born from federal healthcare reform law seeks to boost companies working on therapies that save money.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Medical device firms have good reason to dislike the healthcare reform law. You would, too, if Uncle Sam taxed you $20 billion to pay for it. The industry warned the tax would crush innovation, especially for startups that can't afford it. But tucked away in the law is a little-known tax credit designed to help those very companies.